InvestorsHub Logo
Followers 84
Posts 12550
Boards Moderated 0
Alias Born 07/25/2008

Re: None

Thursday, 09/08/2022 7:01:56 AM

Thursday, September 08, 2022 7:01:56 AM

Post# of 8716
Revance Announces FDA Approval of DAXXIFY™ (DaxibotulinumtoxinA-lanm) for Injection, the First and Only Peptide-Formulated Neuromodulator With Long-Lasting Results
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RVNC News